Results 41 to 50 of about 36,244 (312)

Evaluation of immunoglobulin G level among subjects vaccinated with different types of COVID-19 vaccines in the karbala population, Iraq

Biomedical and Biotechnology Research Journal, 2022
Background: Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) vaccines represent the only way in combating the COVID-19 pandemic. Studying the differences in immune response to different types of vaccines is considered an important tool for ...
Rawaq Taleb Hassan, Suhad H Mohammed
doaj   +1 more source

Real-world Evaluation of the Effectiveness of Sinopharm COVID-19 Vaccine Against Symptomatic COVID-19 in an Omicron-Dominant Setting in Mozambique: A Test-Negative, Case-Control Study. [PDF]

Clin Infect Dis
Background We evaluated the effectiveness of the Sinopharm coronavirus disease 2019 (COVID-19) vaccine, introduced in Mozambique, against the Omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), prevalent from March 2022 to ...
Capitine IU, Aziz AB, Manhiça A, Tivane I, Zumba A, Nhumba M, Rebocho Z, Miquicene E, Nguenha N, Langa J, Shrivastava H, Yang Y, Wang S, Park JY, Kyung SE, You YA, Lee H, Park EL, Rakotozandrindrainy R, Kyoung Jo S, Sherliker C, Sugimoto JD, Jeon HJ, Binger T, Siribie M, Kim DR, Jani IV, Marks F, Tadesse BT.   +28 more
europepmc   +2 more sources

Determination of the ELISA kits for screening convalescence plasma with high potency of SARS-CoV-2 IgG

Zhongguo shuxue zazhi, 2023
Objective To determine the ELISA kit for screening convalescence plasma with high potency of SARS-CoV-2 IgG by comparing and analyzing the plasma detection results of convalescent plasma collected in different periods via ELISA kits from two ...
Zhijun ZHOU, Lu FENG, Shenglan YUE, Yan PENG, Bin GAO, Deiming JI, Juan LI, Kejin CHEN, Lianzhen LIN, Cesheng LI, Yong Hu, Taojing Li   +11 more
doaj   +1 more source

Heterologous COVID-19 Vaccination; Sinopharm and Pfizer-BioNTech

Iraq Medical Journal, 2021
This short communication and highlights is the first one talking about receiving two different Anti-COVID-19  vaccines in full doses. In a small group of almost medical personals in Duhok city, Kurdistan region of Iraq, for the first time in the world 15 doctors who were vaccinated with two doses of Sinopharm at early March were revaccinated with two ...
Ameen M Mohammad, Azri S H Sgery
openaire   +2 more sources

Antibody responses to Sinopharm/BBIBP-CorV in pregnant mothers in Sri Lanka

PLOS Global Public Health, 2022
Background There are limited data regarding the safety and immunogenicity of the Sinopharm/BBIBP-CorV vaccine in pregnancy. Therefore, we sought to investigate the antibody responses and maternal and fetal adverse events following this vaccine in pregnant mothers in Sri Lanka.
Chandima Jeewandara, K. A. Chintha S. Jayampathi, Thushali Ranasinghe, Inoka Sepali Aberathna, Banuri Gunasekara, Saubhagya Danasekara, Thashmi Nimasha, Heshan Kuruppu, Osanda Dissanayake, Nayanathara Gamalath, Dinithi Ekanayake, Jewantha Jayamali, Gayasha Somathilake, Dinuka Guruge, Ruwan Wijayamuni, Achala Kamaladasa, Graham S. Ogg, Gathsaurie Neelika Malavige   +17 more
openaire   +4 more sources

Understanding perception and acceptance of Sinopharm vaccine and vaccination against COVID–19 in the UAE [PDF]

BMC Public Health, 2021
Abstract Background In the current COVID-19 pandemic, the world has reached an important milestone where vaccinations are discovered and are proven to be effective against SARS-COV-2 infections. Though vaccines against COVID-19 are now available, around the globe there is some hesitancy in getting the vaccine.
Faheem Ahamed, Subhashini Ganesan, Anila James, Walid Abbas Zaher   +3 more
openaire   +3 more sources

Effectiveness and Waning of Protection With Different SARS-CoV-2 Primary and Booster Vaccines During the Delta Pandemic Wave in 2021 in Hungary (HUN-VE 3 Study)

Frontiers in Immunology, 2022
BackgroundIn late 2021, the pandemic wave was dominated by the Delta SARS-CoV-2 variant in Hungary. Booster vaccines were offered for the vulnerable population starting from August 2021.MethodsThe nationwide HUN-VE 3 study examined the effectiveness and ...
Zoltán Vokó, Zoltán Vokó, Zoltán Kiss, György Surján, György Surján, Orsolya Surján, Zsófia Barcza, István Wittmann, Gergő Attila Molnár, Dávid Nagy, Dávid Nagy, Veronika Müller, Krisztina Bogos, Péter Nagy, Péter Nagy, Péter Nagy, István Kenessey, István Kenessey, András Wéber, András Wéber, Lőrinc Polivka, Mihály Pálosi, János Szlávik, György Rokszin, György Rokszin, Cecília Müller, Zoltán Szekanecz, Miklós Kásler   +27 more
doaj   +1 more source

Nivel de aceptación de la vacuna Pfizer y Sinopharm en personas adultas que acuden al Centro de Salud Magna Vallejo – Cajamarca, periodo septiembre a octubre, 2021. [PDF]

, 2022
Objetivo: Determinar el nivel de aceptación de la vacuna Pfizer y Sinopharm en las personas adultas que acuden al Centro de Salud Magna Vallejo – Cajamarca, periodo septiembre a octubre 2021. Materiales y métodos: De diseño descriptivo observacional,
Malaver Malca, Elidia Deisy, Davila Silva, Medeleine   +1 more
core  

Efficacy and side effects of Sputnik V, Sinopharm and AstraZeneca vaccines to stop COVID-19; a review and discussion

, 2021
We believe that vaccination is just a way to eliminate or strongly stop the COVID-19. In this regard, there are several vaccines with different efficacy and side effects.
Jahantigh, H. R., Hoseyni, T. S., Arabsorkhi, M., Valizadeh, R., Esfandiari, K., Sadighpour, T., Ghiasi, N.   +6 more
core   +2 more sources

Guillain- Barré Syndrome (GBS) after Sinopharm vaccination

Jaffna Medical Journal, 2022
Neurological complication following Sinopharm vaccination is extremely rare and Guillain-Barre syndrome (GBS) is among the least common complication. Here we report a case of a 62-year-old male with GBS secondary to Sinopharm vaccination. A diagnosed patient with schizophrenia presented with three-day history of lower limb weakness with preceding ...
K. Nirujan, K. Jayasundara, U. Dissanayake   +2 more
openaire   +1 more source